Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. / Nauck, M.A.; Heimesaat, M.M.; Ørskov, C.; Holst, Jens Juul; Ebert, Reinholdt; Creutzfeldt, W.

In: Journal of Clinical Investigation, No. 91, 1993, p. 301-307.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nauck, MA, Heimesaat, MM, Ørskov, C, Holst, JJ, Ebert, R & Creutzfeldt, W 1993, 'Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus', Journal of Clinical Investigation, no. 91, pp. 301-307.

APA

Nauck, M. A., Heimesaat, M. M., Ørskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993). Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation, (91), 301-307.

Vancouver

Nauck MA, Heimesaat MM, Ørskov C, Holst JJ, Ebert R, Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation. 1993;(91):301-307.

Author

Nauck, M.A. ; Heimesaat, M.M. ; Ørskov, C. ; Holst, Jens Juul ; Ebert, Reinholdt ; Creutzfeldt, W. / Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. In: Journal of Clinical Investigation. 1993 ; No. 91. pp. 301-307.

Bibtex

@article{ff6e382074ce11dbbee902004c4f4f50,
title = "Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus",
abstract = "Fysiologi/biofysik",
author = "M.A. Nauck and M.M. Heimesaat and C. {\O}rskov and Holst, {Jens Juul} and Reinholdt Ebert and W. Creutzfeldt",
year = "1993",
language = "English",
pages = "301--307",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "American Society for Clinical Investigation",
number = "91",

}

RIS

TY - JOUR

T1 - Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

AU - Nauck, M.A.

AU - Heimesaat, M.M.

AU - Ørskov, C.

AU - Holst, Jens Juul

AU - Ebert, Reinholdt

AU - Creutzfeldt, W.

PY - 1993

Y1 - 1993

N2 - Fysiologi/biofysik

AB - Fysiologi/biofysik

M3 - Journal article

SP - 301

EP - 307

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 91

ER -

ID: 271708